ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 667 filers reported holding ISHARES TR in Q1 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,025 | -23.8% | 676 | -15.1% | 0.02% | -20.8% |
| Q2 2023 | $102,343 | -1.4% | 796 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $103,823 | -10.7% | 796 | -10.2% | 0.02% | -4.0% |
| Q4 2022 | $116,323 | +0.3% | 886 | -10.6% | 0.02% | -7.4% |
| Q3 2022 | $116,000 | -1.7% | 991 | -1.4% | 0.03% | +3.8% |
| Q2 2022 | $118,000 | -9.9% | 1,005 | 0.0% | 0.03% | +4.0% |
| Q1 2022 | $131,000 | -22.0% | 1,005 | -8.6% | 0.02% | -21.9% |
| Q4 2021 | $168,000 | -13.4% | 1,100 | -8.3% | 0.03% | -15.8% |
| Q3 2021 | $194,000 | -16.7% | 1,200 | -15.8% | 0.04% | -17.4% |
| Q2 2021 | $233,000 | -1.7% | 1,425 | -9.5% | 0.05% | -13.2% |
| Q1 2021 | $237,000 | -11.9% | 1,575 | -20.7% | 0.05% | -18.5% |
| Q3 2020 | $269,000 | -0.7% | 1,985 | 0.0% | 0.06% | -7.1% |
| Q2 2020 | $271,000 | -40.6% | 1,985 | -53.1% | 0.07% | -45.3% |
| Q1 2020 | $456,000 | -20.1% | 4,228 | -10.8% | 0.13% | -4.5% |
| Q4 2019 | $571,000 | +21.2% | 4,738 | 0.0% | 0.13% | +28.8% |
| Q3 2019 | $471,000 | – | 4,738 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |